Dithranol is a reducing agent and DNA-synthesis inhibitor used as a topical therapeutic for chronic plaque psoriasis, one of the oldest effective treatments for this condition. Simson Pharma's Dithranol reference standard and impurities support stability-indicating testing for this highly oxidation-sensitive topical agent.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Dithranol Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.
